info@synchemia.com | sales@synchemia.com 
9766925136 
Enasidenib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Enasidenib is used to treat acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation in patients who have not responded to other treatments or to those whose cancer has come back after treatment.Enasidenib Nitroso Impurity 2 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Enasidenib Nitroso Impurity 2 CAS NO: NA chemically represented as N-(4-((2-Hydroxy-2-methylpropyl)(nitroso)amino)-6-(6-(trifluoromethyl)pyridin-2-yl)-1,3,5-triazin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)nitrous amide. Synchemia is the leading manufacturing and exporter of Enasidenib Nitroso Impurity 2 . We supply Enasidenib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Related Products
| CAT No | SRC-N0143588 |
| CAS No | 64605-07-8 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143589 |
| CAS No | 96724-44-6 |
| Mol.F. | C5H11N3O3 |
| Mol.Wt. | 161.2g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143590 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143591 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143592 |
| CAS No | NA |
| Mol.F. | C28H32N4O3 |
| Mol.Wt. | 472.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143593 |
| CAS No | NA |
| Mol.F. | C24H32N4O5 |
| Mol.Wt. | 456.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143594 |
| CAS No | NA |
| Mol.F. | C10H20N2O8 |
| Mol.Wt. | 296.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143595 |
| CAS No | 854234-69-8 |
| Mol.F. | C13H12N2O |
| Mol.Wt. | 212.25 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143596 |
| CAS No | NA |
| Mol.F. | C5H11ClN2O |
| Mol.Wt. | 150.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143597 |
| CAS No | NA |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143598 |
| CAS No | NA |
| Mol.F. | C20H18N6O3 |
| Mol.Wt. | 390.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143599 |
| CAS No | NA |
| Mol.F. | C21H36N2O3 |
| Mol.Wt. | 364.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143600 |
| CAS No | NA |
| Mol.F. | C13H16N6O3 |
| Mol.Wt. | 304.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143601 |
| CAS No | NA |
| Mol.F. | C18H28N2O6 |
| Mol.Wt. | 368.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143602 |
| CAS No | NA |
| Mol.F. | C11H18N4O6S3 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143603 |
| CAS No | NA |
| Mol.F. | C8H7D6N3OS |
| Mol.Wt. | 205.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
